What does Entrada Therapeutics, Inc. do?
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a…
What is Entrada Therapeutics, Inc.'s P/E and P/B ratio?
Entrada Therapeutics, Inc. has a P/E ratio of -1.2 and a P/B ratio of 0.79.
What is Entrada Therapeutics, Inc.'s debt-to-equity ratio?
Entrada Therapeutics, Inc. has a debt-to-equity ratio of 0.21.
How much does Entrada Therapeutics, Inc. owe compared with what it owns?
Entrada Therapeutics, Inc. owes $0.22 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Entrada Therapeutics, Inc.'s Positivity rank?
Entrada Therapeutics, Inc. is ranked #1,654 of 6,774 companies globally and #397 of 4,000 in United States on PositoAI, with a Positivity Score of 22,448.
Does Entrada Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Entrada Therapeutics, Inc..
Where can I read the latest news about Entrada Therapeutics, Inc.?
Recent headlines about Entrada Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Entrada Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Entrada Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.